Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa)

Forensic Science International

Volumn 132, Issue 1, 2003, Pages 9-17

  Flanagan, R J ^a   Amin, A ^a,b   Seinen, W ^c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b South London and Maudsley Trust   (United Kingdom)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Fatal poisoning: clozapine; Fatal poisoning: interpretation of results; Plasma:whole blood distribution: clozapine; Post mortem redistribution: clozapine

Indexed keywords

CLOZAPINE; NORCLOZAPINE;

ANIMAL TISSUE; ARTICLE; AUTOPSY; BLOOD; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG MUSCLE LEVEL; DRUG TISSUE LEVEL; HEART; HEMATOCRIT; KIDNEY PARENCHYMA; LIVER; MALE; NONHUMAN; PERIPHERAL VEIN; PRIORITY JOURNAL; PROTEIN BINDING; SKELETAL MUSCLE; SWINE;

EID: 0037433379     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(02)00414-0     Document Type: Article

References (47)

1. Meltzer H.Y., Fatemi H. Suicide in schizophrenia: the effect of clozapine. Clin. Neuropharmacol. 18:1995;S18-S24.
2. Axelsson R., Lagerkvist-Briggs M. Factors predicting suicide in psychotic patients. Eur. Arch. Psychiatr. Clin. Neurosci. 241:1992;259-266.
3. Caldwell C.B., Gottesman I.I. Schizophrenia - a high-risk factor for suicide: clues to risk reduction. Suicide Life Threat. Behav. 22:1992;479-493.
4. Le Blaye I., Donatini B., Hall M., Krupp P. Acute overdosage with clozapine: a review of the available clinical experience. Pharm. Med. 6:1992;169-178.
5. Mady S., Wax P., Wang D., Goetz C., Hadley C., Love R. Pediatric clozapine intoxication. Am. J. Emerg. Med. 14:1996;462-463.
6. W.H. Anderson, R.W. Prouty, Postmortem redistribution of drugs, in: R.C. Baselt (Ed.), Advances in Analytical Toxicology, vol. 2, Year Book Medical, Chicago, 1989, pp. 70-102.
7. Prouty R.W., Anderson W.H. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J. Forensic Sci. 35:1990;243-270.
8. Pounder D.J., Jones G.R. Post-mortem drug redistribution - a toxicological nightmare. Forensic Sci. Int. 45:1990;253-263.
9. Hilberg T., Rogde S., Morland J. Postmortem drug redistribution - human cases related to results in experimental animals. J. Forensic Sci. 44:1999;3-9.
10. Jones G.R., Pounder D.J. Site dependence of drug concentrations in postmortem blood - a case study. J. Anal. Toxicol. 11:1987;186-190.
11. Langford A.M., Pounder D.J. Possible markers for postmortem drug redistribution. J. Forensic Sci. 42:1997;88-92.
12. Hilberg T., Bugge A., Beylich K.M., Morland J., Bjorneboe A. Diffusion as a mechanism of postmortem drug redistribution: an experimental study in rats. Int. J. Legal Med. 105:1992;87-91.
13. Hilberg T., Bugge A., Beylich K.M., Ingum J., Bjorneboe A., Morland J. An animal model of postmortem amitriptyline redistribution. J. Forensic Sci. 38:1993;81-90.
14. Hilberg T., Morland J., Bjorneboe A. Postmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution. Forensic Sci. Int. 64:1994;47-55.
15. Hilberg T., Ripel A., Slordal L., Bjorneboe A., Morland J. The extent of postmortem drug redistribution in a rat model. J. Forensic Sci. 44:1999;956-962.
16. Kudo K., Nagata T., Kimura K., Imamura T., Urakawa N. Postmortem changes of triazolam concentrations in body tissues. Nippon Hoigaku Zasshi. 46:1992;293-296.
17. Quatrehomme G., Bourret F., Liao Z., Ollier A. An experimental methodology for the study of postmortem changes in toxic concentrations of drugs, using secobarbital as an example. J. Forensic Sci. 39:1994;1300-1304.
18. Gomez H.F., McKinney P., Phillips S., Roberts D.V., Brent J., Watson W.A. Postmortem acetaminophen pharmacokinetics: an experimental study of site and time-dependent concentration changes. J. Forensic Sci. 40:1995;980-982.
19. Rogde S., Hilberg T., Teige B. Fatal combined intoxication with new antidepressants. Human cases and an experimental study of postmortem moclobemide redistribution. Forensic Sci. Int. 100:1999;109-116.
20. Litterst C.L., Gram T.E., Mimnaugh E.G., Leber P., Emmerling D., Freudenthal R.I. A comprehensive study of in vitro drug metabolism in several laboratory species. Drug Metab. Dispos. 4:1976;203-207.
21. Freudenthal R.I., Leber P., Emmerling D., Kerchner G., Campbell D. Characterization of the hepatic microsomal mixed-function oxidase enzyme system in miniature pigs. Drug Metab. Dispos. 4:1976;25-27.
22. Hilberg T., Ripel A., Smith A.J., Slordal L., Morland J., Bjorneboe A. Postmortem amitriptyline pharmacokinetics in pigs after oral and intravenous routes of administration. J. Forensic Sci. 43:1998;380-387.
23. McCarthy P.T., Hughes S., Paton C. Measurement of clozapine and norclozapine in plasma/serum by high performance liquid chromatography with ultraviolet detection. Biomed. Chromatogr. 9:1995;36-41.
24. Worm K., Kringsholm B., Steentoft A. Clozapine cases with fatal, toxic or therapeutic concentrations. Leg. Med. 106:1993;115-118.
25. Schaber G., Stevens I., Gaertner H.J., Dietz K., Breyer-Pfaff U. Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance. Br. J. Clin. Pharmacol. 46:1998;453-459.
26. Langford A.M., Taylor K.K., Pounder D.J. Drug concentration in selected skeletal muscles. J. Forensic Sci. 43:1998;22-27.
27. Pounder D.J., Adams E., Fuke C., Langford A.M. Site to site variability of postmortem drug concentrations in liver and lung. J. Forensic Sci. 41:1996;927-932.
28. Kaladjian A., Bery B., Deturmeny E., Bruguerolle B. Clozapine monitoring: plasma or serum levels? Ther. Drug Monit. 21:1999;327-329.
29. Bailey D.N. Relative binding of therapeutic drugs by sera of seven mammalian species. J. Anal. Toxicol. 22:1998;587-590.
30. R.C. Baselt, Disposition of Toxic Drugs and Chemicals in Man, 6th ed., Biomedical Publications, Foster City, CA, 2002.
31. Renwick A.C., Renwick A.G., Flanagan R.J., Ferner R.E. Monitoring of clozapine and norclozapine plasma concentration-time curves in acute overdose. J. Toxicol. Clin. Toxicol. 38:2000;325-328.
32. Reith D., Monteleone P.R., Whyte I.M., Ebelling W., Holford N.H.G., Carter G.L. Features and toxicokinetics of clozapine in overdose. Ther. Drug Monit. 20:1998;92-97.
33. Uges D.R., Boom K., Wientjes G.D., Versteege J. Therapeutic drug monitoring of clozapine: an unexpected outcome. Ther. Drug Monit. 22:2000;323-324.
34. Meeker J.E., Herrmann P.W., Som C.W., Reynolds P.C. Clozapine tissue concentrations following an apparent suicidal overdose of Clozaril. J. Anal. Toxicol. 16:1992;54-56.
35. Drummer O.H., Gerostamoulos J. Postmortem drug analysis: analytical and toxicological aspects. Ther. Drug Monit. 24:2002;199-209.
36. de Groot G., Wubs K.L. A simple enzymic digestion procedure of intact tissue samples in pharmacokinetic drug analysis. J. Anal. Toxicol. 11:1987;175-178.
37. Shankar V., Damodaran C., Sekharan P.C. Comparative evaluation of some enzymic digestion procedures in the release of basic drugs from tissue. J. Anal. Toxicol. 11:1987;164-167.
38. Apple F.S. Postmortem tricyclic antidepressant concentrations: assessing cause of death using parent drug to metabolite ratio. J. Anal. Toxicol. 13:1989;197-198.
39. Cirimele V., Kintz P., Gosselin O., Ludes B. Clozapine dose-concentration relationships in plasma, hair and sweat specimens of schizophrenic patients. Forensic Sci. Int. 107:2000;289-300.
40. 1-acid glycoprotein and binding of basic drugs. Methods Find Exp. Clin. Pharmacol. 5:1983;635-648.
41. Fournier T., Medjoubi-N N., Porquet D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta. 1482:2000;157-171.
42. Israili Z.H., Dayton P.G. Human alpha-1-glycoprotein and its interactions with drugs. Drug Metab. Rev. 33:2001;161-235.
43. Weeke B., Krasilnikoff P.A. The concentration of 21 serum proteins in normal children and adults. Acta Med. Scand. 192:1972;149-155.
44. Son D.S., Shimoda M., Kokve E. Implication of altered levels of plasma alpha(1)-acid glycoprotein and its derived sialic acid on plasma protein binding of trimethoprim in pigs in physiological and pathological states. Vet. Q. 18:1996;10-13.
45. A. Rostami-Hodjegan, A. Amin, E.P. Spencer, M.S. Lennard, G.T. Tucker, R.J. Flanagan, Influence of dose, smoking behaviour, clozapine metabolic capacity (plasma clozapine:norclozapine ratio) age, sex, body weight and compliance/concordance on plasma clozapine and norclozapine in clozapine-treated patients, J. Clin. Pharmacol., submitted for publication.
46. Sticht G., Käferstein H., Henssge C. Befunde bei chronischer Einnahme und akuter Überdosierung von Leponex. Beitr. Gerichtl. Med. 47:1989;81-86.
47. Keller T., Miki A., Binda S., Dirnhofer R. Fatal overdose of clozapine. Forensic Sci. Int. 86:1997;119-125.